These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32013413)

  • 21. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA).
    Citti C; Pacchetti B; Vandelli MA; Forni F; Cannazza G
    J Pharm Biomed Anal; 2018 Feb; 149():532-540. PubMed ID: 29182999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
    Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
    J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids.
    Protti M; Rudge J; Sberna AE; Gerra G; Mercolini L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():77-86. PubMed ID: 28088044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
    Freijo TD; Harris SE; Kala SV
    J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea.
    Jang E; Kim H; Jang S; Lee J; Baeck S; In S; Kim E; Kim YU; Han E
    Forensic Sci Int; 2020 Jan; 306():110064. PubMed ID: 31786513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
    Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
    J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of Cannabinoids in Breath Samples Using a Novel Derivatization LC-MS/MS Assay with Ultra-High Sensitivity.
    Luo YR; Yun C; Lynch KL
    J Anal Toxicol; 2019 Jun; 43(5):331-339. PubMed ID: 30951168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS.
    da Cunha KF; Oliveira KD; Huestis MA; Costa JL
    J Anal Toxicol; 2020 Oct; 44(7):697-707. PubMed ID: 32685960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid and convenient sample preparation method for the analysis of cannabinoids in oral fluid samples.
    Reinstadler V; Huber S; Lierheimer S; Boettcher M; Rüscher P; Tanzer M; Jenny K; Zoll A; Gruber W; Oberacher H
    Biomed Chromatogr; 2023 Aug; 37(8):e5651. PubMed ID: 37057387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel single-step GC-MS/MS method for cannabinoids and 11-OH-THC metabolite analysis in hair.
    Angeli I; Casati S; Ravelli A; Minoli M; Orioli M
    J Pharm Biomed Anal; 2018 Jun; 155():1-6. PubMed ID: 29602054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cannabinoids in urine samples of short-term and long-term consumers of hemp seed products.
    Baeck S; Kim B; Cho B; Kim E
    Forensic Sci Int; 2019 Dec; 305():109997. PubMed ID: 31670217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
    Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovative methods for the preparation of medical Cannabis oils with a high content of both cannabinoids and terpenes.
    Ternelli M; Brighenti V; Anceschi L; Poto M; Bertelli D; Licata M; Pellati F
    J Pharm Biomed Anal; 2020 Jul; 186():113296. PubMed ID: 32334134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.